SCHEMBL1702918

SCHEMBL1702918

Cc1ccc(-c2cc(C(C)(C)C)cc3cc(C(NS(C)(=O)=O)C4CNCC4(C)C)cnc23)c(=O)[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2449049 0.84
SCHEMBL1702783 0.84
SCHEMBL1702499 0.83 BRD4 (0.31)
SCHEMBL2446608 0.81 PDE2A (0.30)
SCHEMBL3759270 0.75 BRAF (0.31)
SCHEMBL2448007 0.71 AURKA (0.30)
SCHEMBL1702278 0.70 IKBKB (0.40)
SCHEMBL2448600 0.68 CYP3A4 (0.30)
SCHEMBL1703030 0.68 KCNJ1 (0.31)
SCHEMBL2449045 0.67 AURKA (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2440528-B1 HETEROCYCLIC ANTIVIRAL COMPOUNDS HOFFMANN LA ROCHE (CH) 2014-10-08 EP claimed
EP-2440528-A1 HETEROCYCLIC ANTIVIRAL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2012-04-18 EP claimed
US-8026253-B2 Quinoline inhibitors of HCV polymerase ROCHE PALO ALTO LLC (US) 2011-09-27 US claimed
WO-2010142656-A1 HETEROCYCLIC ANTIVIRAL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2010-12-16 WO claimed
US-20100311760-A1 HETEROCYCLIC ANTIVIRAL COMPOUNDS DE VICENTE FIDALGO JAVIER 2010-12-09 US claimed